EGFR Non-Small Cell Lung Cancer Clinical Trial Pipeline Appears Robust With 37+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
03 juil. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, July 03, 2024 (GLOBE NEWSWIRE) -- EGFR Non-Small Cell Lung Cancer Clinical Trial Pipeline Appears Robust With 37+ Key Pharma Companies Actively Working in the Therapeutics Segment |...